- Latest week
- 10 Jul 2026
- Close
- 10.450000
- Fair value
- 7.454551
- Next-week expectancy
- Undecided 46.31%
BCRX Chart Pack
BioCryst Pharmaceuticals Inc
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, BCRX rose 16.89%, moving from 8.94 to 10.45. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 10.59 and has improved across the 12-week window. Market Dynamics is 0.22 on the latest week. Next-week expectancy is undecided at 46.31% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 10.45
- 12-Week Change
- 16.89%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 46.31%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 10.59
- Market Dynamics
- 0.22
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 10.45
- 12-Week Change
- 16.89%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 46.31%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 10.59
- Market Dynamics
- 0.22
Over the latest 12 completed weeks ending 2026-07-10, BCRX rose 16.89%, moving from 8.94 to 10.45. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 10.59 and has improved across the 12-week window. Market Dynamics is 0.22 on the latest week. Next-week expectancy is undecided at 46.31% based on similar historical setup states.
Industry Peers
United States equities in Drug Manufacturers - Specialty & Generic
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| TLPH Talphera Inc. | NASDAQ | 10 Jul 2026 | 1.06 | 1.50 | 1.00 | 1.46 | 37.74% |
| AKBA Akebia Ther | NASDAQ | 10 Jul 2026 | 1.25 | 1.46 | 1.23 | 1.40 | 12.45% |
| ZYBT Zhengye Biotechnology Holding Limited Ordinary Shares | NASDAQ | 10 Jul 2026 | 0.69 | 0.82 | 0.63 | 0.78 | 12.43% |
| BFRI Biofrontera Inc | NASDAQ | 10 Jul 2026 | 1.04 | 1.21 | 1.03 | 1.10 | 5.77% |
| INM InMed Pharmaceuticals Inc | NASDAQ | 10 Jul 2026 | 1.56 | 1.70 | 1.56 | 1.64 | 5.13% |
| AYTU Aytu BioScience Inc | NASDAQ | 10 Jul 2026 | 2.16 | 2.30 | 2.15 | 2.25 | 4.17% |
| SNOA Sonoma Pharmaceuticals Inc | NASDAQ | 10 Jul 2026 | 1.21 | 1.31 | 1.19 | 1.26 | 4.13% |
| RMTI Rockwell Medical Inc | NASDAQ | 10 Jul 2026 | 5.43 | 6.14 | 5.39 | 5.61 | 3.31% |
| IRWD Ironwood Pharmaceuticals Inc | NASDAQ | 10 Jul 2026 | 4.33 | 4.88 | 4.27 | 4.47 | 3.23% |
| CABR Caring Brands, Inc. Common Stock | NASDAQ | 10 Jul 2026 | 1.30 | 1.52 | 1.30 | 1.34 | 3.08% |
| INDV Indivior PLC Ordinary Shares | NASDAQ | 10 Jul 2026 | 39.41 | 41.60 | 39.20 | 40.50 | 2.77% |
| ANIK Anika Therapeutics Inc | NASDAQ | 10 Jul 2026 | 15.30 | 16.49 | 14.93 | 15.60 | 1.96% |
| SUPN Supernus Pharmaceuticals Inc | NASDAQ | 10 Jul 2026 | 47.62 | 51.37 | 46.76 | 48.46 | 1.76% |
| XERS Xeris Pharmaceuticals Inc | NASDAQ | 10 Jul 2026 | 8.20 | 9.02 | 8.20 | 8.34 | 1.71% |
| CTOR Citius Oncology, Inc. | NASDAQ | 10 Jul 2026 | 0.68 | 0.74 | 0.67 | 0.69 | 1.47% |
| ORGO Organogenesis Holdings Inc | NASDAQ | 10 Jul 2026 | 2.37 | 2.59 | 2.35 | 2.40 | 1.27% |